His bundle mapping, pacing, and injection lead

• US 8,078,287 B2
• Filed: 06/08/2007
• Issued: 12/13/2011
• Est. Priority Date: 12/23/2003
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Liu, Lili, Westlund, Randy, Girouard, Steven D.
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): SARCIONE, JESSICA LYNN
• Application Number:
  US11/760,294
• Publication Number:
  US 20070233216A1
• Time in Patent Office: 1,649 Days
• Field of Search: 607/120, 607/122, 607126-128, 600/381, 600/509
• US Class Current: 607/127
• CPC Class Codes: A61N 1/0568 with drug delivery

Abstract

A cardiac rhythm management system includes a lead assembly for intracardiac mapping, pacing, and drug delivery. The lead assembly includes an implantable endocardial lead having a proximal end for connection to an implantable cardiac rhythm management device and a distal end for disposal in an intracardiac region. The lead includes a pacing-sensing electrode and a drug delivery device, both located at or near the distal end. A lumen is within and extends throughout the lead, with an opening at or near the proximal end and another opening at or near the distal end. The lumen provides for access to the intracardiac region by a steerable stylet and a hollow needle, one at a time. The steerable stylet allows for electrophysiological mapping of the intracardiac region. The hollow needle allows for delivery of chemical, biochemical, and/or biological substance to the intracardiac region.

Claims

1. An implantable endocardial pacing lead assembly for locating and delivering a pacing stimulus to a His bundle of a patient, the lead assembly comprising:

a steerable stylet having a stylet distal end and a stylet proximal end, the steerable stylet including;

a mapping electrode at the stylet distal end;

a connector at the stylet proximal end; and

a conductor electrically coupled between the mapping electrode and the connector;

an implantable lead configured to be implanted in a patient and including;

an elongate lead body having a lead proximal end and a lead distal end;

a connector assembly at the proximal end of the lead body configured for coupling the lead to an implantable device configured to deliver therapy to the patient, the connector assembly including a rotatable terminal pin;

a conductor coil extending within the lead body and mechanically and electrically coupled to the terminal pin;

an extendable and retractable helical electrode at or near the lead distal end for sensing cardiac electrical activities and delivering pacing pulses, wherein the extendable and retractable electrode is rotatable and operable as a fixation helix and is coupled to the conductor coil; and

a lumen within and extending through the lead body, the lumen including a proximal opening at about the lead proximal end and a distal opening at about the lead distal end, the lumen adapted to accommodate at least a portion of the steerable stylet and to allow the stylet distal end to enter the proximal opening and extend from the distal opening.

2. The lead assembly of claim 1, wherein the steerable stylet comprises a nonconductive shell insulating at least a portion of the conductor.

3. The lead assembly of claim 2, wherein the mapping electrode comprises a first terminal portion of the conductor at about the stylet distal end, the first terminal portion of the conductor not insulated by the nonconductive shell.

4. The lead assembly of claim 3, wherein the connector comprises a second terminal portion of the conductor at about the stylet proximal end, the second terminal portion of the conductor not insulated by the nonconductive shell.

5. The lead assembly of claim 1, wherein the implantable lead further comprises a drug delivery device at or near the lead distal end for delivering a pharmaceutical substance.

6. The lead assembly of claim 5, wherein the drug delivery device comprises a silicone polymeric collar to contain the pharmaceutical substance.

7. The lead assembly of claim 6, wherein the drug delivery device comprises an osmotic membrane and a drug reservoir containing the pharmaceutical substance.

8. The lead assembly of claim 7, wherein the pharmaceutical substance comprises one or more agents preventing a degeneration of a cardiac conductive system.